Read More 1 minute read Analyst Ratings News Price Target Upgrades JP Morgan Upgrades Regeneron Pharmaceuticals to Overweight, Announces $850 Price Target By Benzinga Newsdesk Today, 11:54 PM JP Morgan analyst Chris Schott upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) from Neutral to Overweight and announces $850 price target. REGN
Read More 1 minute read Analyst Ratings News Price Target Upgrades Barclays Upgrades PVH to Overweight, Raises Price Target to $106 By Benzinga Newsdesk Today, 11:54 PM Barclays analyst Adrienne Yih upgrades PVH (NYSE:PVH) from Equal-Weight to Overweight and raises the price target from $72 to $106. PVH
Read More 1 minute read Analyst Ratings News Price Target Upgrades Morgan Stanley Upgrades PagerDuty to Overweight, Raises Price Target to $36 By Benzinga Newsdesk Today, 11:54 PM Morgan Stanley analyst Sanjit Singh upgrades PagerDuty (NYSE:PD) from Equal-Weight to Overweight and raises the price target from $32 to $36. PD
Read More 1 minute read Analyst Ratings News Price Target Upgrades Canaccord Genuity Upgrades Coeur Mining to Hold, Raises Price Target to $4 By Benzinga Newsdesk Today, 11:54 PM Canaccord Genuity analyst Dalton Baretto upgrades Coeur Mining (NYSE:CDE) from Sell to Hold and raises the price target from $3 to $4. CDE
Read More 1 minute read Analyst Ratings News Price Target Upgrades Susquehanna Upgrades Universal Display to Neutral, Raises Price Target to $135 By Benzinga Newsdesk Today, 11:54 PM Susquehanna analyst Mehdi Hosseini upgrades Universal Display (NASDAQ:OLED) from Negative to Neutral and raises the price target from $82 to $135. OLED
Read More 1 minute read Analyst Ratings News Price Target Upgrades Jefferies Upgrades Philip Morris Intl to Buy, Announces $118 Price Target By Benzinga Newsdesk Today, 11:54 PM Jefferies analyst Owen Bennett upgrades Philip Morris Intl (NYSE:PM) from Hold to Buy and announces $118 price target. PM
Read More 1 minute read Analyst Ratings News Price Target Upgrades UBS Upgrades CureVac to Buy, Announces $18 Price Target By Benzinga Newsdesk Today, 11:54 PM UBS analyst Eliana Merle upgrades CureVac (NASDAQ:CVAC) from Neutral to Buy and announces $18 price target. CVAC
Read More 1 minute read Analyst Ratings News Price Target Upgrades Keybanc Upgrades Chegg to Overweight, Announces $29 Price Target By Benzinga Newsdesk Today, 11:54 PM Keybanc analyst Jason Celino upgrades Chegg (NYSE:CHGG) from Sector Weight to Overweight and announces $29 price target. CHGG
Read More 1 minute read Analyst Color Analyst Ratings Downgrades General Health Care Movers News Price Target Small Cap Trading Ideas Upgrades Raymond James Upgrades Natera & Myriad Genetics, While Downgrading This Stock By Vandana Singh Today, 11:54 PM Raymond James upgraded Natera Inc (NASDAQ:NTRA) to Outperform from Market Perform and a price target of $58 on a catalyst-rich setup for 2023… MYGN
Read More 2 minute read Analyst Ratings Markets Mid Cap News Price Target Tech Top Stories Trading Ideas Upgrades Seagate Technology Poised For Early Cycle Rebound, Says Morgan Stanley Analyst By AJ Fabino Today, 11:54 PM Analysts at Morgan Stanley upgraded Seagate Technology Holdings PLC (NASDAQ: STX) Wednesday, suggesting that the IT hardware industry is entering the final stages of the late cycle and is poised for an early-cycle rebound. STX